HWKOA
Asset Logo

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Hawk Resources Limited - Option Expiring 09-Sep-2025

📈 Performance

Price History

N/A

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in HWKOA

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in HWKOA

N/A
HWKOA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in HWKOA also invest in...

Want more shares? Try these...

Hexima Limited

HXL

Hexima Ltd. is a clinical stage, anti-infectives focused biotechnology company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-01. The firm is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.

📊 Share price

$0.01 AUD

🧬 BIOTECHNOLOGY

Find Out More

Hydrix Ltd. engages in the development, design, and commercialization of technologies in the micro-electronic-mechanical systems (MEMS) sensor industry. The company is headquartered in Mulgrave, Victoria and currently employs 60 full-time employees. The company went IPO on 2001-05-11. The firm is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.

🙌 Performance (5Yr p.a)

-19.09%

📊 Share price

$0.01 AUD

🔨 COMMERCIAL SERVICES & SUPPLIES

🙌 Performance (5Yr p.a)

-6.67%

📊 Share price

$0.02 AUD

HWKO

📊 Share price

$0.00 AUD
Compare
Add to watchlist